As we demonstrated that there is a positive correlation between EGFR expression and PD-L1 expression status, the overexpression of EGFR may be a determinant of treatment response to immunotherapy targeting PD1/PD-L1 axis in the lung cancers that arise in these smoking population. The gene discussed is CD274; the disease is lung carcinoma.